Glenmark Pharmaceuticals Ltd. (GLENMARK)
Market Closed
10 Aug, 22:00
MSE XNSE Primary MSE ₹
2,255. 15
-31.85
-1.3927%
₹
- Market Cap
- P/E Ratio
10% Div Yield
7,178 Volume
- Eps
₹ 2,287
Previous Close Want to track GLENMARK and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | 12.1 | 7.21 |
| | | 13.9 | 20.73 |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | 7.77 |
| | | - | 7.72 |
| | | - | 5.07 |
| | | - | 6.03 |
| | | - | 7.01 |
| | | - | 6.91 |
| | | - | 0.39 |
| | | - | 4.23 |
| | | - | 6.08 |
| | | - | 6.81 |
| | | - | 1.59 |
| | | - | 7.97 |
| | | - | 5.69 |
| | | - | 4.75 |
| | | - | 6.16 |
| | | - | 7.86 |
GLENMARK Earnings Reports FAQ
What is the earnings per share (EPS) for GLENMARK?
EPS data for GLENMARK is currently not available, as Glenmark Pharmaceuticals Ltd has not reported recent earnings.
What is the company's earnings growth rate?
Over the past 13 years, the earnings growth rate has been approximately -0.72%, reflecting the GLENMARK's performance and MSE market conditions.
When is the next earnings release date?
Glenmark Pharmaceuticals Ltd has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Glenmark Pharmaceuticals Ltd are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for GLENMARK at this time, as Glenmark Pharmaceuticals Ltd has no recent EPS data to calculate it.
